In defense of basic science - my new video about how we balance basic vs. translational science: youtu.be/yl6ETxRfQn8?si=lEim…. . And why we should encourage a culture of wandering to solve problems:. A team effort between @UniofOxford and @OxfordSparks.
Every so often, a major event happens in your life to validate years of work. SRRK’s ISEMBYLD was FDA approved. Having participated in its development from basic science to approval, as a physician-scientist, this is one of my best days. Happy for ISEMBYLD to help SMA patients.
Doing a PhD is - at heart - one long discussion with your mentor. The discussion changes over time - with unexpected turns and ups & downs - but through it all is two people discussing a topic endlessly to make sense of it. PhD students: choose someone you like to talk to.
Are you our next Director?
We’re looking for an inspirational scientific leader who is ready to shape the direction of one of the world's leading cancer discovery research centres, a department of the University of Cambridge and core-funded @CR_UK
See: wittkieffer.com/positions/a1…
Four Oxford academics have been honoured in the 2026 @royalsociety Awards. 🎉
Congratulations to:
Prof Laura Herz
Prof Iain McCulloch
Prof Ketan Patel
Prof Charlotte Williams
Read more ⬇️
ox.ac.uk/news/2026-08-26-fou…
Neural niches are recurrent features of human cancer that may relay signals to nearby cells, to the immune system, + to the brain. So what’s in these niches, and what happens when cancer cells barge in? We take a look under the hood in our new preprint 1/ biorxiv.org/content/10.64898…
Jim Shorter and his postdoc Miriam wrote a beautiful preview of our most recent paper on mRNA preventing misfolding of IDR-containing proteins.
UTR-ly unexpected: RNA chaperones tame intrinsically disordered proteins: Cell cell.com/cell/fulltext/S0092…
Scientists from MSK and @WeillCornell found that a small subset of T cells, called stem T cells, are responsible for making new T cells and continuously replenishing them in chronic disease.
"We've identified what we believe is a fundamental mechanism, one that the immune system uses broadly to sustain itself in chronic disease," says MSK cancer immunologist Dr. Andrea Schietinger.
Learn more: bit.ly/3TgSLbb
The ZDM19 meeting in Oxford is coming up soon! We have a great list of speakers, lots of early career researcher events, and an amazing location in the heart of Oxford. Registration is open now but early bird pricing will end soon - so please register as soon as possible! zdmsociety.org/zdm19-registr…
It's a two-fer Tuesday. We are ecstatic to share this preprint from our amazing postdoc @CNFXC. Corey solved a long-standing question in the field of transport biology, identifying SLC16A6 as a melanosomal tyrosine transporter.
We are excited to share a new preprint from our amazing postdoc @alexjbott ! Alex designed a new CRISPR screening platform called TRoUT-FISH to identify transcriptional activators and repressors of various genes of interest! Check out his tweetorial below!
Happy to share our new preprint from @RutterLab. To understand how genes are controlled, we developed a method we call TRoUT-FISH, using CRISPR + RNA-FISH. We found that glycolytic gene expression is fine-tuned by lineage specifying transcription factors.
biorxiv.org/content/10.64898…
Dear Friends, I just published an insightful review on neural crest evolutionary origin and later transformations.
“Co-option and innovation in neural crest evolution”: science.org/doi/10.1126/scia…
How does mechanical force influence blood flow? In @NorthTrista new paper, they show it happens through Yap/Taz and Piezo1. Congrats to first author Wade Sugen @sugden_wade and the rest of the team! Check out the link: biorxiv.org/content/10.64898…
Since the 1960s, the genetic code has been used to predict protein sequences from DNA and mRNA sequences. Our @Nature article demonstrates that these predictions miss thousands of protein sequences present in human tissues.
Across >1,000 human samples, we identified numerous abundant proteins whose amino acid sequences differ from those predicted by the genetic code.
These proteins are not rare translation byproducts. They accumulate to thousands of copies per cell. Some are more abundant than the proteins predicted by the genetic code from the same transcripts.
Their abundance reflects a combination of alternate RNA decoding mechanisms — including codon-anticodon mismatches, tRNA abundance, and RNA modifications — and selective stabilization of the resulting proteins. The last factor – protein stability – emerges as a major determinant of protein abundance across proteins, proteoforms and cell types: slavovlab.net/research.htm#P…
Alternate RNA decoding is pervasive across functional groups of proteins, healthy and diseased tissues. It affects proteins playing key roles in neurodegeneration, and some alternately decoded proteins show strong enrichment in tumors compared to their surrounding tissues.
This discovery has been a long and exhilarating journey with Shira Tsour and the @slavovLab team. It started in 2019 and proceeded through many challenges and thrilling highs. A journey that has opened new perspectives that we long to explore!
1/